Search Results 1-10 of 27092 for what%20is%20vedolizumab

  1. Vedolizumab (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Entyvio. Descriptions. Vedolizumab injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is a monoclonal ...

  2. Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis - Mayo Clinic

    A head-to-head comparison suggests that vedolizumab is slightly superior to adalimumab for moderately to severely active ulcerative colitis and should be ...

  3. Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate perianal fistula healing at Week 30 in 2 different dose regimens of vedolizumab intravenous (IV) 300 milligram (mg) in ...

  4. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

    ... ulcerative colitis activity index (PUCAI) of >= 20 points from baseline for participants with UC; or a reduction of the CDAI as defined by a >= 70-point ...

  5. A Study of Vedolizumab in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

    The purpose of this study is to determine the long-term safety of vedolizumab intravenous (IV) treatment in pediatric participants with Ulcerative Colitis (UC) ...

  6. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Crohn's Disease Clinical Trials - Mayo Clinic Research

    20 patients (age 12 to 17 years) with Crohns perianal fistulas will be enrolled. Subjects will undergo standard adjuvant therapy including drainage of infection ...

  8. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

    ... Crohn's disease (CD) who achieved clinical response following administration of vedolizumab intravenous (vedolizumab IV) induction therapy. Participation ...

  9. Crohn's Disease Clinical Trials - Mayo Clinic Research

    ... vedolizumab versus other biologic agents in participants with Ulcerative Colitis or Crohn's Disease. ... 20 million cells. 20 patients (age 12 to 17 years) ...

  10. A Study Comparing the Long Term Safety of Entyvio (Vedolizumab) to Other Biologic Agents in Patients with Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis or Crohn's ...